VCYT · Veracyte Inc
United States · RS rating 91 · As of 2026-11-03
| Price | 50.29 USD |
|---|---|
| 1-day change | +2.6% |
| RS rating (overall / 1M / 3M / 12M) | 91 / 73 / 81 / 80 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 47 / 37 / 59 |
| Industry group (rank) | Medical-Research Eqp/Svc (46) |
| EPS growth Q/Q | +112.5% |
| Sales growth Q/Q | +6.7% |
| Distance from 52-week high | +16.9% |
| Market cap (USD) | $2.6B |